Coya Therapeutics, Inc.COYANASDAQ

Revenue (LTM)

$8M

+123.6% YoY

Net Income (LTM)

$-21M

-42.6% YoY

Free Cash Flow

$-11M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	6	4↓40.8%	8↑123.6%
Gross Profit	0	-4	1↑111.3%	-8↓1760.1%	8↑195.3%
Operating Income	-5	-10↓101.5%	-8↑19.5%	-17↓118.3%	-20↓17.5%
Net Income	-5	-12↓150.3%	-8↑34.8%	-15↓86.3%	-21↓42.6%
EBITDA	-5	-9↓90.8%	-7↑20.8%	-17↓134.5%	-20↓17.7%
EPS Diluted	-0.74	-1.23↓66.3%	-0.79↑35.8%	-0.98↓24.1%	-1.27↓29.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	4	6↑36.7%	33↑449.9%	38↑17.5%	47↑22.1%
Total Current Assets	5	7↑56.7%	41↑473.4%	44↑7.6%	50↑12.7%
Total Assets	5	8↑75.2%	41↑391.5%	44↑7.5%	50↑12.6%
Total Current Liabilities	1	4↑233.0%	5↑32.1%	4↓24.3%	6↑53.5%
Total Liabilities	1	17↑1362.0%	6↓66.5%	5↓15.2%	7↑45.1%
Total Equity	4	-8↓330.4%	36↑524.6%	40↑11.1%	43↑8.7%
Total Debt	0	13	0	0	0
Net Debt	-4	7↑262.0%	-33↓564.0%	-38↓17.5%	-47↓22.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-4	-7↓85.5%	-11↓54.6%	-10↑8.0%	-11↓4.4%
Capital Expenditure	-0	0	0	0	0
Free Cash Flow	-4	-7↓79.2%	-11↓54.6%	-10↑8.0%	-11↓4.4%
Stock-Based Comp	0	0↓11.1%	1↑320.7%	3↑205.4%	4↑61.1%
Net Change in Cash	-4	2↑136.4%	27↑1575.1%	6↓78.6%	8↑48.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance